Institute for International Research

Now in its 4th year, the GP Summit keeps you informed on rapidly changing reporting requirements, and provides the tools to ensure correct pricing calculations to achieve compliance excellence in Government Programs. The GP Summit has 14 seasoned state and federal government officials represented on the speaking faculty along with industry rebate experts who represent large, mid-sized and small pharmaceutical and generics manufacturers. This event is designed to share collective understanding of each program, including: new calculation methodologies, how healthcare reform will impact government programs and a clear view on how the program can work well, with solutions to challenges.

IIR’s Forced Degradation Forum is returning and updated with ALL NEW information and updates on the latest forced degradation insights and advances. Over the last six years, IIR’s Forced Degradation conferences have become catalysts for scientific progress and improvements in forced degradation testing and analysis. Join IIR and event co-founders Karen Alsante (Pfizer) and Steve Baertschi (Eli Lilly), for another ground-breaking event that addresses the latest challenges at the 6th annual Forced Degradation Forum.

Now in its 14th year, the eClinical Technology Summit encompasses the next generation of clinical data management. Obtain cutting edge strategies for collecting, integrating and reporting data through the strategic implementation of clinical technologies. What’s more, with the largest industry clinical trials event as its back drop, Partnerships with Clinical Trials, experience unparalleled networking opportunities with over 1500 industry peers.

A New Decade of Opportunities and Challenges for the Pharma PM

The Medicaid Managed Care Congress provides Medicaid professionals who share the common goal of maintaining quality and access while containing Medicaid program costs an opportunity to share best practices, position for pending regulatory changes and obtain proven strategies for innovation in quality, access and efficiency.

In its 13 year history, the Medicaid Drug Rebate Program has become the Nation’s largest and most well-respected government programs pharmaceutical rebates and contracting event bringing together senior Pharmaceutical executives and top CMS, HHS and OIG officials to under one roof to prepare for changing regulations, respond to pending litigation and position for future development in Medicaid, 340B, and TriCare.